首页> 外文期刊>European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery >Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass.
【24h】

Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass.

机译:心肺血液回输不会在体外循环期间触发全身性凝血。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: During cardiopulmonary bypass (CPB), systemic coagulation is believed to become activated by blood contact with the extracorporeal circuit and by retransfusion of pericardial blood. To which extent retransfusion activates systemic coagulation, however, is unknown. We investigated to which extent retransfusion of pericardial blood triggers systemic coagulation during CPB. Methods: Thirteen patients undergoing elective coronary artery bypass grafting surgery were included. Pericardial blood was retransfused into nine patients and retained in four patients. Systemic samples were collected before, during and after CPB, and pericardial samples before retransfusion. Levels of prothrombin fragment F(1+2) (ELISA), microparticles (flow cytometry) and non-cell bound (soluble) tissue factor (sTF; ELISA) were determined. Results: Compared to systemic blood, pericardial blood contained elevated levels of F(1+2), microparticles and sTF. During CPB, systemic levels of F(1+2) increased from 0.28 (0.25-0.37;median, interquartile range) to 1.10 (0.49-1.55) nmol/l (p=0.001). This observed increase was similar to the estimated (calculated) increase (p=0.424), and differed significantly between retransfused and non-retransfused patients (1.12nmol/l vs 0.02nmol/l, p=0.001). Also, the observed systemic increases of platelet- and erythrocyte-derived microparticles and sTF were in line with predicted increases (p=0.868, p=0.778 and p=0.205, respectively). Before neutralization of heparin, microparticles and other coagulant phospholipids decreased from 464mug/ml (287-701) to 163mug/ml (121-389) in retransfused patients (p=0.001), indicating rapid clearance after retransfusion. Conclusion: Retransfusion of pericardial blood does not activate systemic coagulation under heparinization. The observed increases in systemic levels of F(1+2), microparticles and sTF during CPB are explained by dilution of retransfused pericardial blood.
机译:目的:在体外循环(CPB)期间,人们认为血液与体外循环接触以及通过心包血的再输注会激活全身性凝血。然而,再输血在多大程度上激活全身性凝结尚不清楚。我们研究了心包血液的再输血在CPB期间触发全身凝血的程度。方法:纳入13例行择期冠状动脉搭桥术的患者。心包血被重新输入9名患者,并保留在4名患者中。在CPB之前,期间和之后收集全身样本,在再次输血之前收集心包样本。确定凝血酶原片段F(1 + 2)(ELISA),微粒(流式细胞仪)和非细胞结合(可溶性)组织因子(sTF; ELISA)的水平。结果:与全身血相比,心包血中F(1 + 2),微粒和sTF含量升高。在CPB期间,F(1 + 2)的全身水平从0.28(0.25-0.37;中位数,四分位数范围)增加到1.10(0.49-1.55)nmol / l(p = 0.001)。观察到的这种增加与估计的(计算得出的)增加相似(p = 0.424),并且在再输血和未再输血患者之间存在显着差异(1.12nmol / l与0.02nmol / l,p = 0.001)。同样,观察到的血小板和红细胞来源的微粒和sTF的全身性增加与预测的增加一致(分别为p = 0.868,p = 0.778和p = 0.205)。在中和肝素之前,再输血患者中的微粒和其他凝血磷脂从464 ug / ml(287-701)降至163 ug / ml(121-389)(p = 0.001),表明再输血后迅速清除。结论:在肝素化的情况下,心包血的回输不能激活全身性凝血。在CPB期间观察到的系统性F(1 + 2),微粒和sTF的水平升高是由重输的心包血稀释引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号